
Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022
Description
Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022
Summary
GlobalData's Medical Devices sector report, “Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 provides comprehensive information about the Abdominal Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development- Develop market-entry and market expansion strategies- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Summary
GlobalData's Medical Devices sector report, “Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 provides comprehensive information about the Abdominal Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Abdominal Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development- Develop market-entry and market expansion strategies- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
72 Pages
- About GlobalData
- Abdominal Aortic Stent Grafts Overview
- Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
- Abdominal Aortic Stent Grafts - Pipeline Products by Territory
- Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
- Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
- Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
- Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
- Abdominal Aortic Stent Grafts – Companies Pipeline Products by Stage of Development
- Affluent Medical SA Company Overview
- Angiolutions UG Company Overview
- BiFlow Medical Ltd Company Overview
- Cook Medical Inc Company Overview
- Cytograft Tissue Engineering Inc (Inactive) Company Overview
- Endologix LLC Company Overview
- Endoluminal Sciences Pty Ltd. Company Overview
- Hadassah Medical Center Company Overview
- Johns Hopkins University Company Overview
- JOTEC GmbH Company Overview
- Kawasumi Laboratories Inc Company Overview
- Lombard Medical Technologies Inc. Company Overview
- Lombard Medical Technologies Ltd (Inactive) Company Overview
- Medtronic Plc Company Overview
- St. Jude Medical LLC Company Overview
- Terumo Aortic Company Overview
- University of Colorado Denver Company Overview
- University of Limerick Company Overview
- Venus MedTech Company Overview
- Feb 24, 2022: LeMaitre Q4 2021 Financial Results
- Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
- Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
- Dec 09, 2021: Cordis appoints Dr. George Adams to Chief Medical Officer
- Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China
- Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
- Oct 28, 2021: LeMaitre Q3 2021 Financial Results
- Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
- Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center
- Sep 21, 2021: Shimadzu receives Vizient contract for cardiac and vascular interventional systems and general radiology systems
- Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
- Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
- Jul 29, 2021: LeMaitre Q2 2021 Financial Results
- Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
- Jul 13, 2021: LeMaitre Provides Q2 2021 Update
- May 20, 2021: Getinge Flow Family Anesthesia machines awarded contract with Vizient
- May 17, 2021: MicroPort Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital
- Apr 29, 2021: LeMaitre Q1 2021 Financial Results
- Apr 14, 2021: LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
- Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.